Repare Therapeutics Inc. stock is up 3.89% since 30 days ago. The next earnings date is May 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 February’s closed higher than January. 100% of analysts rate it a buy.
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach. Its lead product candidate is an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. The company was incorporated in 2016 and is headquartered in Montreal, Canada.
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!